简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Research
HOME
·
Premia China STAR50 ETF
Premia China STAR50 ETF (03151.HK) Falls 2.73% to HKD 12.110
Tags:
Premia China STAR50 ETF
03151.HK
ETF
2026-05-14
Premia China STAR50 ETF(03151.HK) rose 4.88% to close at HKD 10.960
Tags:
ETF
Premia China STAR50 ETF
03151.HK
2026-04-30
Premia China STAR50 ETF(03151.HK) rose 3.54% to HKD 10.820
Tags:
ETF
Premia China STAR50 ETF
03151.HK
2026-04-30
Semiconductor and Memory Chip Surge Propels Premia China STAR 50 ETF (03151.HK) Up Over 2%
Tags:
03151.HK
ETF
Premia China STAR50 ETF
2026-04-14
Premia China STAR50 ETF (03151.HK) rose more than 2% at one point intraday, a powerful tool for Hong Kong stock market to deploy high-quality assets in A-share hard technology
Tags:
Premia China STAR50 ETF
03151.HK
SSE STAR Market 50 Index
2026-01-08
Hard-tech surges: Premia China STAR50 ETF (83151.HK) rallies for a third straight day.
Tags:
Premia China STAR50 ETF
NewTimeSpace
83151.OF
2026-01-06
Previous
1
2
Featured News
Finance
Estun (02715.HK): Positive Profit Forecast, Interim Net Profit Attributable to Parent Expected to Surge Around 21 to 26 Times
Finance
CHINA DEVELOPMENT BANK FINANCIAL LEASING(01606.HK): Acquisition of Three Vessels at Consideration Not Exceeding USD 138 Million
Finance
Holly Futures(03678.HK): Independent Director Zhang Hongfa Resigns
Finance
Shenwan Hongyuan (06806.HK): Shenwan Hongyuan Securities Obtains Registration Approval for Perpetual Subordinated Bonds with a Ceiling of RMB 30 Billion
Finance
Luxxu Group(01327.HK): Executive Director Yang Xi Resigns; Liang Yanhuang Appointed as Authorised Representative
Finance
United Laboratories (03933.HK): New Specification of Sodium Hyaluronate Eye Drops Approved for Marketing
Finance
Dongjiang Environmental (00895.HK): 2026 Interim Performance Forecast, Expected Net Loss of RMB 250 Million to RMB 270 Million
Finance
CSPC Pharmaceutical Group (01093.HK): Albumin-Bound Docetaxel Combined with Anitumab Granted Breakthrough Therapy Designation
Finance
China Everbright Water (01857.HK): Completes Issuance of Phase 1 Medium-Term Notes of 2026 with Principal of RMB 1.5 Billion
Finance
MicroTech Medical(02235.HK): Continuous Glucose Monitoring System Secures Marketing Approval in South Korea
Scan QR Code
Download App